From October 1, 2023 to December 31, 2023, the company has repurchased 957,000 shares, representing 0.21% for $26.15 million. With this, the company has completed the repurchase of 9,846,000 shares, representing 2.19% for $304.77 million under the buyback announced on March 28, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.54 USD | -1.43% |
|
-3.05% | -5.46% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.46% | 12.17B | |
+51.60% | 791B | |
+40.45% | 630B | |
+17.11% | 328B | |
+8.94% | 298B | |
+17.25% | 246B | |
+0.41% | 225B | |
+10.22% | 218B | |
+4.57% | 160B | |
-6.05% | 156B |
- Stock Market
- Equities
- RPRX Stock
- News Royalty Pharma plc
- Tranche Update on Royalty Pharma plc's Equity Buyback Plan announced on March 28, 2023.